1Department of Nephrology, Graduate School of Medicine, Chiba University, Chiba, Japan
2Faculty of Medicine, Airlangga University, Surabaya, Indonesia
3Sohyaku, Innovative Research Division, Mitsubishi Tanabe Pharmaceutical Corporation, Kanagawa, Japan
4Medical Innovation Center, TMK project, Graduate School of Medicine, Kyoto University, Kyoto, Japan
5Department of Nephrology, Kyoto University Hospital, Kyoto, Japan
6Karolinska Institute/AstraZeneca Integrated Cardio Metabolic Center (ICMC), Huddinge, Sweden
7Division of Pathology, Department of Laboratory Medicine, Karolinska University Hospital Huddinge, Huddinge, Sweden
8Department of Bioregulation and Pharmacological Medicine and Department of Obesity and Internal Inflammation, Fukushima Medical University, Fukushima City, Japan
aCorrespondence: Katsuhiko Asanuma, MD, PhD, Department of Nephrology, Graduate School of Medicine, Chiba University 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, JAPAN, Phone: +81-43-222-7171, Fax: +81-45-266-2607, Email: [email protected]
留言 (0)